Ontrak inks deal with Intermountain Health, forecasts revenue jump

EditorAhmed Abdulazez Abdulkadir
Published 01/09/2025, 01:08 AM
OTRK
-

Ontrak, Inc. (NASDAQ:OTRK), a provider of healthcare solutions currently trading at $1.80 per share, announced today a significant partnership with Intermountain Health aimed at expanding its Wholehealth+ solution to Medicare Advantage members. This collaboration is expected to bolster Ontrak's annualized revenue from existing customers by an estimated 25%, a crucial development given the company's current revenue of $11.24 million over the last twelve months.

The newly signed agreement positions Ontrak to increase its forecasted annualized revenue to between $14 million and $16 million, a notable rise from the previously projected range of $11 million to $13 million. The deal with Intermountain Health represents a strategic move for Ontrak as it continues to grow its customer base and enhance its service offerings to the healthcare market. According to InvestingPro data, this growth is particularly important as analysts had previously anticipated a 15% sales decline for the current year.

Ontrak, which has undergone several name changes in its history, with the most recent being from Catasys (NASDAQ:OTRK), Inc., is headquartered in Miami, FL, and operates under the healthcare and allied services industry. The collaboration with Intermountain Health is part of Ontrak's ongoing efforts to provide comprehensive healthcare services to a broader demographic.

The company's stock, trading under the symbol OTRK on The NASDAQ Capital Market, may see investor interest following this announcement as it reflects the company's growth trajectory and potential for increased revenue streams. InvestingPro analysis indicates the stock is currently undervalued, though investors should note its volatile price movements, with the stock down nearly 67% over the past year and trading well below its 52-week high of $16.05.

This development is based on an 8-K filing with the Securities and Exchange Commission, as reported by Ontrak, Inc. on January 8, 2025. The company's Chief Financial Officer, James J. Park, signed off on the report, ensuring compliance with the regulatory requirements of the SEC.

Investors and stakeholders in the healthcare services sector will be watching Ontrak's progress closely as it implements its Wholehealth+ solution with Intermountain Health and works to realize the anticipated revenue growth from this and other customer engagements. For deeper insights into Ontrak's financial health and growth prospects, including 8 additional ProTips and comprehensive valuation metrics, investors can access the full analysis through InvestingPro's detailed research report.

In other recent news, Ontrak Health announced its Q3 2024 financial results, revealing a revenue of $2.6 million, a 31% decrease compared to the same period last year. This drop in revenue is attributed to the loss of a customer earlier in the year. However, the company reported new customer acquisitions and expansions, including a significant partnership with Sentara Health Plans. Ontrak's AI-driven engagement system has achieved more than double the industry standard outreach success rate.

In light of these recent developments, the company anticipates a 12% to 23% sequential increase in Q4 2024 revenues. Current contracts are expected to generate $11 million to $13 million of annual revenue, and Q4 2024 revenue is projected to be between $2.9 million and $3.2 million. Despite a decline in revenue per health plan enrolled member per month and a negative operating cash flow for Q3 at $1.4 million, Ontrak Health continues to navigate the healthcare market with its specialized programs and AI-driven engagement systems.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.